Daniel Levy, M.D., director of the famed Framingham Heart Study, will deliver the seventh annual Meredith S. and John A. Oates Lecture in Clinical Pharmacology on Thursday, Nov. 14.

The Vanderbilt Comprehensive Care Clinic has received a nearly $40,000 grant for 2013-2014 from the Baptist Healing Trust (BHT) for its Pharmacy Support Program, which provides free or low-cost medications to people with HIV/AIDS.

Ken Lau, Ph.D., a new assistant professor in Cell and Developmental Biology, is out to determine the rules that lead to cells converting from one type to another, for example, when a healthy cell becomes a cancer cell.

Vanderbilt researchers have characterized the chemical structures of a series of DNA-protein “crosslinks” that may lead to better ways to avoid the cancer-causing potential of environmental chemicals and prevent some drug toxicities.

A multidisciplinary study conducted by the combined efforts of Vanderbilt University graduate students has led to the first evidence that abnormal messenger RNA export from the nucleus to the cytoplasm can cause human disease.

Inactivation by oxidative stress of specific transcription factors essential for pancreatic islet beta cell function is a key event in the development of type 2 diabetes, Vanderbilt University researchers and their colleagues have found.